In small-cell lung cancer (SCLC), FGF-2 signalling activates S6K2-dependent phosphorylation of hnRNPA1 at serines 4 and 6, selectively enhancing expression of the anti-apoptotic XIAP and Bcl-xL protein. This evidence concerns the gene RPS6KB2 and small cell lung carcinoma.